Literature DB >> 19003269

Isolation and purification of colon lamina propria dendritic cells from mice with colitis.

Maureen L Drakes1, Steven J Czinn, Thomas G Blanchard.   

Abstract

Dendritic cells are prime antigen presenting cells for stimulation of T cell immune responses. These cells are present in trace amounts in normal tissue. At sites of disease the increased frequency of these cells interacting with T cells may provide the basis for the release of pro-inflammatory mediators and contribute to localised cell and tissue damage. Studies on dendritic cells in the colon lamina propria of inflammatory bowel disease (IBD) mice have been limited due to the difficulties encountered in the isolation and purification of sufficient numbers of these cells. This is the first detailed, reproducible method provided in the literature for the isolation of colon lamina propria dendritic cells from mice with colitis, yielding optimum purity of cells and sufficient numbers to advance the study of dendritic cell function in the colons of mice. The most frequently used identification marker of murine DC is the CD11c surface antigen. We have adapted, combined, and improved procedures developed for the isolation of other cell types, to develop an efficient procedure for the isolation of dendritic cells from colon tissue. This protocol describes a step-by-step method for optimising the purity and recovery of lamina propria CD11c+ dendritic cells from mice colons.

Entities:  

Year:  2005        PMID: 19003269      PMCID: PMC3449714          DOI: 10.1007/s10616-005-2552-6

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  18 in total

1.  Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition.

Authors:  Venu G Pillarisetty; Alaap B Shah; George Miller; Joshua I Bleier; Ronald P DeMatteo
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 2.  The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria.

Authors:  A J Stagg; A L Hart; S C Knight; M A Kamm
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

3.  Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion.

Authors:  F D Finkelman; A Lees; R Birnbaum; W C Gause; S C Morris
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

Review 4.  Dendritic cells: unique leukocyte populations which control the primary immune response.

Authors:  D N Hart
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

5.  Functional properties of lymphocytes isolated from murine small intestinal epithelium.

Authors:  S B Dillon; T T MacDonald
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

6.  Expression of immunoglobulin isotypes by lymphoid cells of mouse intestinal lamina propria.

Authors:  J Tseng
Journal:  Cell Immunol       Date:  1982-11-01       Impact factor: 4.868

7.  Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine.

Authors:  M D Davies; D M Parrott
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

8.  Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine.

Authors:  P J Van der Heijden; W Stok
Journal:  J Immunol Methods       Date:  1987-11-05       Impact factor: 2.303

9.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

10.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.

Authors:  P J Morrissey; K Charrier; S Braddy; D Liggitt; J D Watson
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  8 in total

1.  Inverse relationship between dendritic cell CCR9 expression and maturation state.

Authors:  Maureen L Drakes; Patrick J Stiff; Thomas G Blanchard
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

2.  Exacerbated experimental colitis in TNFAIP8-deficient mice.

Authors:  Honghong Sun; Yunwei Lou; Thomas Porturas; Samantha Morrissey; George Luo; Ji Qi; Qingguo Ruan; Songlin Shi; Youhai H Chen
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

3.  Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C.

Authors:  Joseph M Reynolds; Gustavo J Martinez; Kalyan C Nallaparaju; Seon Hee Chang; Yi-Hong Wang; Chen Dong
Journal:  J Immunol       Date:  2012-09-28       Impact factor: 5.422

4.  Regulation of murine dendritic cell immune responses by Helicobacter felis antigen.

Authors:  Maureen L Drakes; Steven J Czinn; Thomas G Blanchard
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.

Authors:  Nainong Li; Ying Chen; Wei He; Tangsheng Yi; Dongchang Zhao; Chunyan Zhang; Chia-Lei Lin; Ivan Todorov; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

6.  The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.

Authors:  Xiaolei Pei; Danfeng Zheng; Shaoping She; Jing Ma; Changyuan Guo; Xiaoning Mo; Yingmei Zhang; Quansheng Song; Yu Zhang; Dalong Ma; Ying Wang
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

7.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

Review 8.  Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies.

Authors:  Amandip Kaur; Paraskevi Goggolidou
Journal:  J Inflamm (Lond)       Date:  2020-04-21       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.